Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of iTBS on Cognitive Control in Children With ADHD: A Randomized, Sham-Controlled Study Integrating EEG During ANT, fNIRS, MRI, and Genetic Markers

NCT07182344 is registered in ClinicalTrials.gov with Neurolab Plus as lead sponsor.

NCT NCT07182344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of iTBS on Cognitive Control in Children With ADHD: A Randomized, Sham-Controlled Study Integrating EEG During ANT, fNIRS, MRI, and Genetic Markers
Lead sponsor
Neurolab Plus
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 4, 2025
Completion date
June 30, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adhd - attention deficit disorder with hyperactivity